101 related articles for article (PubMed ID: 2557994)
1. Possible mechanisms of action of the antiphospholipid binding antibodies.
Khamashta MA; Asherson RA; Hughes GR
Clin Exp Rheumatol; 1989; 7 Suppl 3():S85-9. PubMed ID: 2557994
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?
Oosting JD; Derksen RH; Bobbink IW; Hackeng TM; Bouma BN; de Groot PG
Blood; 1993 May; 81(10):2618-25. PubMed ID: 8166780
[TBL] [Abstract][Full Text] [Related]
3. The antiphospholipid antibody dilemma.
Derksen RH; Hasselaar P; Oosting JD; De Groot PG
Clin Rheumatol; 1990 Mar; 9(1 Suppl 1):39-44. PubMed ID: 2168305
[No Abstract] [Full Text] [Related]
4. [Antiphospholipid antibodies: specificity and mechanism of action].
Tobelem G
Ann Med Interne (Paris); 1990; 141(3):257-60. PubMed ID: 2114812
[TBL] [Abstract][Full Text] [Related]
5. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
Bertolaccini ML; Hughes GR; Khamashta MA
Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
[TBL] [Abstract][Full Text] [Related]
6. Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin.
Tsakiris DA; Settas L; Makris PE; Marbet GA
J Rheumatol; 1990 Jun; 17(6):785-9. PubMed ID: 2167370
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.
Yasuda S; Bohgaki M; Atsumi T; Koike T
Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497
[TBL] [Abstract][Full Text] [Related]
8. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro.
Gharavi AE; Pierangeli SS; Colden-Stanfield M; Liu XW; Espinola RG; Harris EN
J Immunol; 1999 Sep; 163(5):2922-7. PubMed ID: 10453040
[TBL] [Abstract][Full Text] [Related]
9. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome.
Forastiero R; Martinuzzo M
Lupus; 2008 Oct; 17(10):872-7. PubMed ID: 18827051
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.
Pengo V; Biasiolo A; Brocco T; Tonetto S; Ruffatti A
Thromb Haemost; 1996 May; 75(5):721-4. PubMed ID: 8725712
[TBL] [Abstract][Full Text] [Related]
11. Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosis.
Chen PP; Yang CD; Ede K; Wu CC; FitzGerald JD; Grossman JM
Lupus; 2008 Oct; 17(10):916-21. PubMed ID: 18827056
[TBL] [Abstract][Full Text] [Related]
12. Protein C.
Esmon CT
Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.
Pierangeli SS; Chen PP; Raschi E; Scurati S; Grossi C; Borghi MO; Palomo I; Harris EN; Meroni PL
Semin Thromb Hemost; 2008 Apr; 34(3):236-50. PubMed ID: 18720303
[TBL] [Abstract][Full Text] [Related]
14. [The role of anticardiolipin antibodies in the pathogenesis of arterial and venous thromboses].
Eber B
Acta Med Austriaca; 1990; 17(4):67-70. PubMed ID: 2291381
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of anti-beta 2-glycoprotein I antibodies.
Amengual O; Atsumi T; Khamashta MA; Hughes GR
Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():15-7. PubMed ID: 8952753
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies: origin, specificity, and mechanism of action.
Brey RL; Coull BM
Stroke; 1992 Feb; 23(2 Suppl):I15-8. PubMed ID: 1561668
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis.
Hasselaar P; Derksen RH; Blokzijl L; de Groot PG
Thromb Haemost; 1988 Feb; 59(1):80-5. PubMed ID: 3129812
[TBL] [Abstract][Full Text] [Related]
18. Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin.
Vega-Ostertag M; Harris EN; Pierangeli SS
Arthritis Rheum; 2004 Sep; 50(9):2911-9. PubMed ID: 15457460
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies directed against the epidermal growth factor-like domains of thrombomodulin inhibit protein C activation in vitro.
Oosting JD; Preissner KT; Derksen RH; de Groot PG
Br J Haematol; 1993 Dec; 85(4):761-8. PubMed ID: 7522520
[TBL] [Abstract][Full Text] [Related]
20. Physiopathology of thrombosis induced by antiphospholipid antibodies.
Zini JM
Clin Rev Allergy Immunol; 1995; 13(1):5-9. PubMed ID: 7648349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
